drugset / Trial / NCT02659488
Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects
NaSingle-groupOpen-label
Summary
The purpose of this study is to explore the effect of Lisdexamfetamine on Prefrontal Brain Dysfunction in Binge Eating Disorder
Timeline
- Start
- 2015-09
- Primary completion
- 2017-09
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lisdexamfetamine | Other / unclassified | 50 mg | — |
| Subject | Lisdexamfetamine | Other / unclassified | 70 mg | — |